In his new role, he will lead the growth strategy for the group’s operations, including Apothecon Pharmaceuticals in India and Navinta LLC in the United States
Giri stated he is stepping down to pursue new opportunities after careful consideration
Giri is currently the President (India Business & Emerging Markets) of Amneal Pharmaceuticals
The base Gland business posted ?11,790 million in revenue, up 16% YoY
Revenue for the quarter rose 5.8% to Rs. 1,487 crore as compared to Rs. 1,406 crore in the corresponding quarter of the previous fiscal
Cenexi reports an EBITDA breakeven for the quarter
Our Q3 FY25 revenue was at Rs. 1,384.1 crore with an EBITDA of Rs. 360 crore resulting in a 26% EBITDA margin
Morepen Laboratories approves hiving off of medical devices business
Subscribe To Our Newsletter & Stay Updated
